摘要:
A 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative represented by the general formula: ##STR1## wherein R.sup.1 is a hydrogen atom or a lower alkyl group; R.sup.2 is a hydrogen atom, a lower alkyl group, a lower alkanoyl group, a halogenated lower alkanoyl group or a residue of carboxylic acid ester; R.sup.3 is a hydrogen atom or a lower alkyl group; R.sup.4, R.sup.5 or R.sup.6 are each independently a hydrogen atom or a lower alkyl group; or two of R.sup.4, R.sup.5 and R.sup.6 may be taken together to form a --(CH.sub.2).sub.n -group wherein n is 1 or 2, a stereoisomer thereof, or a pharmacologically acceptable salt thereof, the process for preparing these compounds, a pharmaceutical composition comprising an effective amount of these compounds and methods for the treatment of infectious diseases through the administration to patients of an effective amount of these compounds, and intermediates of these compounds are disclosed. These compounds are effective as antibacterial agents.
摘要:
5-Amino-7-((3S,4S)-3-amino-4-methyl (or ethyl)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acid or a pharmacologically acceptable salt thereof represented by the following formula wherein asymmetric carbon atoms marked with asterisks are in the S-configurations and R.sup.1 represents methyl group or ethyl group; and an antibacterial agent comprising said compound as an active ingredient. ##STR1##
摘要:
A thiazetoquinoline-3-carboxylic acid derivative represented by the general formula (I) ##STR1## wherein R.sub.1 is a hydrogen atom or a lower alkyl group; R.sub.2 is a fluorine atom or a chlorine atom; R.sub.3 is a hydrogen atom, a lower alkyl group, a lower alkanoyl group, a halogenated lower alkanoyl, or alkoxycarbonyl group; and R.sub.4 is a hydrogen atom or a lower alkyl group, and a pharmacologically acceptable salt thereof, a process for preparation thereof, a pharmaceutical composition comprising the same, and a method for the treatment of an infectious disease by administering the same, are disclosed.
摘要:
Novel alpha-aminoalkyl-alpha-alkylphenylacetonitrile derivatives useful for treatment of cartino vaso diseases, a peripheral circulatory insufficiency and cerebral circulation failure are disclosed.
摘要:
This invention relates to solid polymer electrolyte materials for use in one or more electrode of a fuel cell. The solid polymer electrolyte materials comprise one or more ionomer which comprises polymerized units of monomers A and monomers B, wherein monomers A are perfluoro dioxole or perfluoro dioxolane monomers, and the monomers B are functionalized perfluoro olefins having fluoroalkyl sulfonyl, fluoroalkyl sulfonate or fluoroalkyl sulfonic acid pendant groups, CF2═CF(O)[CF2]nSO2X. The ionomer of the solid polymer electrolyte material has a number average molecular weight, Mn, of greater than 140,000. Specifically, the ionomers of the invention may find use in the catalyst layer of an electrode because the high molecular weight ionomers mitigate the formation of cracks in the catalyst layer.
摘要翻译:本发明涉及用于燃料电池的一个或多个电极的固体聚合物电解质材料。 固体聚合物电解质材料包含一种或多种离聚物,其包含单体A和单体B的聚合单元,其中单体A是全氟二氧杂环戊烯单体或全氟二氧戊环单体,单体B是具有氟代烷基磺酰基,氟烷基磺酸酯或氟烷基磺酸的全氟烯烃的官能化 侧链基团,CF 2 = CF(O)[CF 2] n SO 2 X。 固体高分子电解质材料的离聚物的数均分子量Mn大于14万。 具体地,本发明的离聚物可用于电极的催化剂层,因为高分子量离聚物可以减轻催化剂层中的裂纹的形成。
摘要:
A fuel cell-purpose electrolyte material having a structural unit represented by a general formula (1): where n is 0 or a positive integer, and R1 represents H or CH3, and R2 represents (CH2)mSO3H (m is 0 or a positive integer).
摘要翻译:一种具有由通式(1)表示的结构单元的燃料电池用电解质材料:其中n为0或正整数,并且R 1表示H或CH 3,并且R 2表示(CH 2)m SO 3 H(m为0或正 整数)。
摘要:
The present invention is directed to a fuel oil for diesel engines, which is reduced in the discharges of particulate matters (PM) and carbon dioxide (CO) in exhaust gas upon combustion while retaining a high cetane number, characterized in that the fuel oil composition comprises a mineral oil as a principal component; and(a) 2-13 wt % of one or more dialkyl phthalate compounds represented by the chemical formula (1), and(b) 2-13 wt % of one or more glycol ether compounds represented by the chemical formula (2); andthe total content of said components (a) and (b) is from 4 to 15 wt %.
摘要:
A light wavelength converter which includes a light source for emitting fundamental waves having a desired wavelength, a first loop-shaped optical waveguide for converting the fundemental waves into harmonics, and a second optical waveguide for receiving the light from the source, wherein the two waveguides are coupled by an optical directional coupler.
摘要:
A light wavelength converter comprising a substrate that is made of a material with a non-linear optical effect, and a loop-shaped optical waveguide that is formed on the substrate, whereby a second harmonic wave or a sum wave emanates from a fundamental wave that has been propagated in a specific area of the optical waveguide and part of the fundamental wave that has not been converted to the second harmonic wave or the sum wave is returned to the specific area of the optical waveguide, so that a fundamental wave with a relatively low output can be efficiently converted to a second harmonic wave and a high-output second harmonic wave can be obtained.
摘要:
A semiconductor laser element of the present invention provides a double hetero junction structure having two clad layers and an active layer formed between the two clad layers. High resistance regions are formed vertically to the light propagating direction at almost the same interval as the light wavelength in at least one of the two clad layers. The high resistance regions form a periodic current blocking structure so the semiconductor laser element may oscillate in a single longitudinal mode even in a non-steady state operation.